These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12658736)

  • 21. Low expression of Ku70/80, but high expression of DNA-PKcs, predict good response to radiotherapy in early breast cancer.
    Söderlund Leifler K; Queseth S; Fornander T; Askmalm MS
    Int J Oncol; 2010 Dec; 37(6):1547-54. PubMed ID: 21042724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lethality of Ku86 (XRCC5) loss-of-function mutations in human cells is independent of p53 (TP53).
    Ghosh G; Li G; Myung K; Hendrickson EA
    Radiat Res; 2007 Jan; 167(1):66-79. PubMed ID: 17214517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma.
    Shintani S; Mihara M; Li C; Nakahara Y; Hino S; Nakashiro K; Hamakawa H
    Cancer Sci; 2003 Oct; 94(10):894-900. PubMed ID: 14556663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
    Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
    Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Ku86 and DNA-PKcs deficiency on non-homologous end-joining and homologous recombination using a transient transfection assay.
    Secretan MB; Scuric Z; Oshima J; Bishop AJ; Howlett NG; Yau D; Schiestl RH
    Mutat Res; 2004 Oct; 554(1-2):351-64. PubMed ID: 15450431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer.
    Hosoi Y; Watanabe T; Nakagawa K; Matsumoto Y; Enomoto A; Morita A; Nagawa H; Suzuki N
    Int J Oncol; 2004 Aug; 25(2):461-8. PubMed ID: 15254745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
    Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
    Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal DNA-PKcs and Ku 70/80 expression may promote malignant pathological processes in gastric carcinoma.
    Li W; Xie C; Yang Z; Chen J; Lu NH
    World J Gastroenterol; 2013 Oct; 19(40):6894-901. PubMed ID: 24187467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KARP-1: a novel leucine zipper protein expressed from the Ku86 autoantigen locus is implicated in the control of DNA-dependent protein kinase activity.
    Myung K; He DM; Lee SE; Hendrickson EA
    EMBO J; 1997 Jun; 16(11):3172-84. PubMed ID: 9214634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of proteins binding to E-box/Ku86 sites and function of Ku86 in transcriptional regulation of the human xanthine oxidoreductase gene.
    Xu P; LaVallee PA; Lin JJ; Hoidal JR
    J Biol Chem; 2004 Apr; 279(16):16057-63. PubMed ID: 14761964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo.
    Li GC; He F; Shao X; Urano M; Shen L; Kim D; Borrelli M; Leibel SA; Gutin PH; Ling CC
    Cancer Res; 2003 Jun; 63(12):3268-74. PubMed ID: 12810658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
    M'kacher R; Bennaceur A; Farace F; Laugé A; Plassa LF; Wittmer E; Dossou J; Violot D; Deutsch E; Bourhis J; Stoppa-Lyonnet D; Ribrag V; Carde P; Parmentier C; Bernheim A; Turhan AG
    Oncogene; 2003 Sep; 22(39):7905-12. PubMed ID: 12970738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
    Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC
    J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances.
    Kwon MJ; Kim DH; Park HR; Shin HS; Kwon JH; Lee DJ; Kim JH; Cho SJ; Nam ES
    Hum Pathol; 2014 Jul; 45(7):1327-38. PubMed ID: 24810547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein.
    Muller C; Dusseau C; Calsou P; Salles B
    Oncogene; 1998 Mar; 16(12):1553-60. PubMed ID: 9569022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.